Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MX69-114b
i
Other names:
MX69-114b
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Emory University
Drug class:
MDM2 protein degrader
‹
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
MDM2 overexpression
Acute Lymphocytic Leukemia
MDM2 overexpression
Acute Lymphocytic Leukemia
MX69-114b
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
MX69-114b
Sensitive
:
D
AACR 2023 - 1wk
MX69-114b
Sensitive: D – Preclinical
AACR 2023 - 1 week
MX69-114b
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login